Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$43.70
+1.5%
$43.87
$39.57
▼
$101.91
$63.34B0.618.66 million shs13.21 million shs
Penumbra, Inc. stock logo
PEN
Penumbra
$320.40
+0.4%
$320.15
$276.72
▼
$362.41
$12.63B0.71571,550 shs214,390 shs
Stryker Corporation stock logo
SYK
Stryker
$317.97
+0.1%
$293.26
$267.00
▼
$389.33
$121.05B0.782.53 million shs3.28 million shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$103.41
+1.3%
$96.00
$79.12
▼
$112.54
$19.57B0.52.27 million shs2.34 million shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
-1.55%-3.60%-2.90%-17.24%-57.67%
Penumbra, Inc. stock logo
PEN
Penumbra
-0.36%-0.63%-0.47%-2.36%+14.59%
Stryker Corporation stock logo
SYK
Stryker
+2.23%-2.10%+7.77%-6.76%-11.75%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
+0.66%-4.93%+7.66%+1.51%+15.16%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$43.70
+1.5%
$43.87
$39.57
▼
$101.91
$63.34B0.618.66 million shs13.21 million shs
Penumbra, Inc. stock logo
PEN
Penumbra
$320.40
+0.4%
$320.15
$276.72
▼
$362.41
$12.63B0.71571,550 shs214,390 shs
Stryker Corporation stock logo
SYK
Stryker
$317.97
+0.1%
$293.26
$267.00
▼
$389.33
$121.05B0.782.53 million shs3.28 million shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$103.41
+1.3%
$96.00
$79.12
▼
$112.54
$19.57B0.52.27 million shs2.34 million shs
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Corporation stock logo
BSX
Boston Scientific
-1.55%-3.60%-2.90%-17.24%-57.67%
Penumbra, Inc. stock logo
PEN
Penumbra
-0.36%-0.63%-0.47%-2.36%+14.59%
Stryker Corporation stock logo
SYK
Stryker
+2.23%-2.10%+7.77%-6.76%-11.75%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
+0.66%-4.93%+7.66%+1.51%+15.16%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Boston Scientific Corporation stock logo
BSX
Boston Scientific
2.65
Moderate Buy$61.4340.59% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.18
Hold$367.0714.57% Upside
Stryker Corporation stock logo
SYK
Stryker
2.75
Moderate Buy$343.778.12% Upside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.29
Hold$114.3210.54% Upside

Current Analyst Ratings Breakdown

Latest ZBH, PEN, SYK, and BSX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/18/2026
Stryker Corporation stock logo
SYK
Stryker
Boost Price TargetBuy$304.00 ➝ $345.00
11/17/2026
Penumbra, Inc. stock logo
PEN
Penumbra
Reiterated RatingHold$374.00
11/17/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
UpgradeEqual Weight ➝ Overweight$113.00 ➝ $123.00
11/16/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Lower Price TargetMarket Perform$102.00 ➝ $101.00
11/16/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Boost Price TargetBuy$125.00 ➝ $140.00
11/9/2026
Stryker Corporation stock logo
SYK
Stryker
Boost Price TargetOverweight$325.00 ➝ $350.00
11/9/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Boost Price TargetEqual Weight$100.00 ➝ $115.00
11/5/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Set Price Target$114.00
11/5/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Boost Price TargetBuy$120.00 ➝ $130.00
11/5/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Boost Price TargetNeutral$117.00 ➝ $120.00
11/5/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Boost Price TargetNeutral$99.00 ➝ $117.00
(Data available from 11/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$20.07B3.16$4.03 per share10.83$17.85 per share2.45
Penumbra, Inc. stock logo
PEN
Penumbra
$1.40B9.00$4.30 per share74.58$40.18 per share7.97
Stryker Corporation stock logo
SYK
Stryker
$25.12B4.82$17.29 per share18.39$61.62 per share5.16
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$8.23B2.38$14.01 per share7.38$67.24 per share1.54
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$2.90B$2.3618.5214.141.2916.62%18.61%10.58%2/3/2027 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$177.69M$3.9780.7052.35N/A10.06%10.39%8.09%N/A
Stryker Corporation stock logo
SYK
Stryker
$3.25B$9.3933.8619.582.1313.78%23.74%11.64%2/4/2027 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$705.20M$3.9526.1811.622.388.95%13.02%7.17%N/A

Latest ZBH, PEN, SYK, and BSX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.88$1.90+$0.02$1.00$2.04 billion$2.06 billion
10/29/2026Q3 2026
Penumbra, Inc. stock logo
PEN
Penumbra
$1.20$1.07-$0.13$1.07$401.41 million$410.15 million
10/29/2026Q3 2026
Stryker Corporation stock logo
SYK
Stryker
$3.55$3.52-$0.03$1.96$6.62 billion$6.52 billion
10/28/2026Q3 2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.7270$0.73+$0.0030$0.40$5.09 billion$5.14 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
Stryker Corporation stock logo
SYK
Stryker
$3.521.10%+7.58%37.49%32 Years
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.960.93%N/A24.30%N/A

Latest ZBH, PEN, SYK, and BSX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/28/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.241.08%9/30/20269/30/202610/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.42
1.36
0.81
Penumbra, Inc. stock logo
PEN
Penumbra
0.01
5.89
3.92
Stryker Corporation stock logo
SYK
Stryker
0.60
2.18
1.30
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.49
1.46
0.79

Institutional Ownership

CompanyInstitutional Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
Stryker Corporation stock logo
SYK
Stryker
77.09%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.34%
Penumbra, Inc. stock logo
PEN
Penumbra
2.90%
Stryker Corporation stock logo
SYK
Stryker
4.60%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
1.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
59,0001.45 billion1.44 billionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,70039.41 million38.27 millionOptionable
Stryker Corporation stock logo
SYK
Stryker
56,000380.69 million363.18 millionOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
17,000189.25 million186.83 millionOptionable

Recent News About These Companies

Zimmer Biomet (NYSE:ZBH) Upgraded at Wells Fargo & Company
Zimmer Biomet (ZBH) PT Raised to $140 at Stifel
Zimmer Biomet (NYSE:ZBH) Stock Rating Raised to Buy at Wall Street Zen
What Zimmer Biomet (ZBH) Said on Its Q3 Earnings Call
Zimmer Biomet (NYSE:ZBH) Price Target Raised to $130.00
Zimmer Biomet Holdings (ZBH) Gets a Hold from Citi

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Boston Scientific stock logo

Boston Scientific NYSE:BSX

$43.70 +0.67 (+1.55%)
Closing price 03:59 PM Eastern
Extended Trading
$43.65 -0.05 (-0.11%)
As of 06:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Penumbra stock logo

Penumbra NYSE:PEN

$320.40 +1.29 (+0.40%)
Closing price 03:59 PM Eastern
Extended Trading
$320.52 +0.13 (+0.04%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Stryker stock logo

Stryker NYSE:SYK

$317.96 +0.43 (+0.13%)
Closing price 03:59 PM Eastern
Extended Trading
$318.48 +0.51 (+0.16%)
As of 06:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$103.41 +1.32 (+1.30%)
Closing price 03:59 PM Eastern
Extended Trading
$103.39 -0.02 (-0.02%)
As of 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.